Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17237239rdf:typepubmed:Citationlld:pubmed
pubmed-article:17237239lifeskim:mentionsumls-concept:C1882687lld:lifeskim
pubmed-article:17237239lifeskim:mentionsumls-concept:C1955862lld:lifeskim
pubmed-article:17237239lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:17237239pubmed:issue5lld:pubmed
pubmed-article:17237239pubmed:dateCreated2007-5-9lld:pubmed
pubmed-article:17237239pubmed:abstractTextThe present study was conducted to determine whether the infarct sparing effect of short-term exercise is dependent on the operation of the myocardial sarcolemmal ATP-sensitive K(+) (K(ATP)) channel. Adult male and female Sprague-Dawley rats were exercised on a motorized treadmill for 5 days. Twenty-four hours following the training or sedentary period, hearts were isolated and exposed to 1 h of regional ischemia followed by 2 h of reperfusion on a modified Langendorf apparatus in the presence or absence of the sarcolemmal K(ATP) channel antagonist HMR-1098 (30 microM). Following the ischemia-reperfusion protocol, infarct size was determined as a percentage of the total ischemic zone at risk (ZAR). Short-term exercise reduced infarct size by 24% in males (32 +/- 2% of ZAR; P < 0.01) and by 18% in females (26 +/- 2% of ZAR; P < 0.05). Sarcolemmal K(ATP) channel blockade abolished the training-induced cardioprotection in both males and females, increasing infarct size to 43 +/- 3% and 52 +/- 4% of ZAR, respectively. In the absence of HMR-1098, infarct size was significantly lower in sedentary females than in males (33 +/- 4% vs. 42 +/- 2% of ZAR, respectively; P < 0.01). However, the presence of HMR-1098 abolished this sex difference, increasing infarct size by 58% in the sedentary females (P < 0.01) but having no effect on infarct size in sedentary males. This study demonstrates that the sex-specific and exercise-acquired resistance to myocardial ischemia-reperfusion injury is dependent on sarcolemmal K(ATP) activity during ischemia.lld:pubmed
pubmed-article:17237239pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:languageenglld:pubmed
pubmed-article:17237239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:citationSubsetIMlld:pubmed
pubmed-article:17237239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17237239pubmed:statusMEDLINElld:pubmed
pubmed-article:17237239pubmed:monthMaylld:pubmed
pubmed-article:17237239pubmed:issn0363-6135lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:MooreRussell...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:LynchJoshua...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:ArmstrongCase...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:JohnsonMicah...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:ChiccoAdam...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:GardnerRyan...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:FasenGeoff...lld:pubmed
pubmed-article:17237239pubmed:authorpubmed-author:GillenwaterCo...lld:pubmed
pubmed-article:17237239pubmed:issnTypePrintlld:pubmed
pubmed-article:17237239pubmed:volume292lld:pubmed
pubmed-article:17237239pubmed:ownerNLMlld:pubmed
pubmed-article:17237239pubmed:authorsCompleteYlld:pubmed
pubmed-article:17237239pubmed:paginationH2432-7lld:pubmed
pubmed-article:17237239pubmed:dateRevised2007-12-3lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:meshHeadingpubmed-meshheading:17237239...lld:pubmed
pubmed-article:17237239pubmed:year2007lld:pubmed
pubmed-article:17237239pubmed:articleTitleSex-specific and exercise-acquired cardioprotection is abolished by sarcolemmal KATP channel blockade in the rat heart.lld:pubmed
pubmed-article:17237239pubmed:affiliationDepartment of Integrative Physiology, University of Colorado at Boulder, Boulder, CO 80309, USA.lld:pubmed
pubmed-article:17237239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17237239pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17237239pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17237239lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17237239lld:pubmed